Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 442 participants.
Also called NCT06099730
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 442 participants
- Registry
-
NCT06099730
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT06099730. Allocation not applicable; no masking; primary purpose treatment. Start 2023-12-14 (actual); primary completion 2028-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF
- Acronym
- POLARIS
- Condition
- Atrial Fibrillation
- Intervention (Device)
- Pulsed Field Ablation (PFA)
- Lead sponsor
- Massachusetts General Hospital
Record details
- Record id
cardio:ct-nct06099730- Content hash
26a0685c9cc34f39f878f04290a59d89d0966da5fddaeadb3b8f3851fee8a9ea